Evidence map›Paper›PMID 26200180›Full record

Trial reportAnesthesiology2015

Hyperinsulinemic Normoglycemia Does Not Meaningfully Improve Myocardial Performance during Cardiac Surgery: A Randomized Trial.

Andra E Duncan, Babak Kateby Kashy, Sheryar Sarwar, Akhil Singh, Olga Stenina-Adognravi, Steffen Christoffersen, Andrej Alfirevic, Shiva Sale, Dongsheng Yang, James D Thomas and 2 more

Registry-linked trialOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Anesthesiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00524472 (The Effect of Hyperinsulinemic Glucose Control on Outcomes Following Cardiac Surgery), which is not on this map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00524472 nacompletednot on this map

The Effect of Hyperinsulinemic Glucose Control on Outcomes Following Cardiac Surgery

TypeinterventionalSponsorThe Cleveland ClinicRan2007 to 2015Enrolled1,439ConditionsCardiac SurgeryArmsHyperinsulinemic-normoglycemic clamp, insulin at the standard of care levels
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Perioperative glycaemic control for people with diabetes undergoing surgery.The Cochrane database of systematic reviews · 2023
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 1 institution in 2 countries.

Andra E DuncanFrom the Departments of Cardiothoracic Anesthesia (A.E.D., A.A., S. Sale), Outcomes Research (A.E.D., B.K.K., S. Sarwar, A.S., D.Y., D.I.S.), Molecular Cardiology (O.S.-A., S.C.), Quantitative Health Sciences (D.Y.), Cardiovascular Medicine (J.D.T.), and Cardiac Surgery (M.G.), Cleveland Clinic, Cleveland, Ohio. Current affiliations: Department of Anesthesiology, Northwestern University, Chicago, Illinois (B.K.K.); Department of Family Medicine, Case Medical Center, University Hospitals of Cleveland, Cleveland, Ohio (S.Sarwar); Hepatobiliary Anesthesia, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada (A.S.); Case Western Reserve University, Cleveland, Ohio (S.C.); and Bluhm Cardiovascular Institute, Northwestern Memorial Hospital, Chicago, Illinois (J.D.T.).
Babak Kateby Kashy
Sheryar Sarwar
Akhil Singh
Olga Stenina-Adognravi
Steffen Christoffersen
Andrej Alfirevic
Shiva Sale
Dongsheng Yang
James D Thomas
Marc Gillinov
Daniel I Sessler
Northwestern University · US

Funding

Clinical and Translational Science Collaborative of ClevelandUL1TR000439 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$50.0M
TSP-4 genetic variants in atherogenesis and angiogenesisR01HL117216 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI PLOW, EDWARD FRANKLIN, STENINA, OLGA I · 2013 to 2017
$1.9M
Tissue Specific Regulation of Diabetes-Associated Cancer GrowthR01CA177771 · NCI · CLEVELAND CLINIC LERNER COM-CWRU · PI STENINA, OLGA I · 2014 to 2018
$1.6M
Regulation of thrombospondin-1 expression by glucoseR01DK067532 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI STENINA, OLGA I · 2006 to 2010
$1.4M
Hyperinsulinemic glucose control and myocardial function during cardiac surgeryK23HL093065 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI DUNCAN, ANDRA E · 2010 to 2014
$774k
NCATS NIH HHS UL1 TR000439NCI NIH HHS R01 CA177771NCI NIH HHS R01CA177771NHLBI NIH HHS K23 HL093065NHLBI NIH HHS R01 HL117216NHLBI NIH HHS R01HL117216NIDDK NIH HHS R01 DK067532NIDDK NIH HHS R01DK067532
6 · The paper itself

Abstract

backgroundGlucose-insulin-potassium (GIK) administration during cardiac surgery inconsistently improves myocardial function, perhaps because hyperglycemia negates the beneficial effects of GIK. The hyperinsulinemic normoglycemic clamp (HNC) technique may better enhance the myocardial benefits of GIK. The authors extended previous GIK investigations by (1) targeting normoglycemia while administering a GIK infusion (HNC); (2) using improved echocardiographic measures of myocardial deformation, specifically myocardial longitudinal strain and strain rate; and (3) assessing the activation of glucose metabolic pathways.

methodsA total of 100 patients having aortic valve replacement for aortic stenosis were randomly assigned to HNC (high-dose insulin with concomitant glucose infusion titrated to normoglycemia) versus standard therapy (insulin treatment if glucose >150 mg/dl). The primary outcomes were left ventricular longitudinal strain and strain rate, assessed using speckle-tracking echocardiography. Right atrial tissue was analyzed for activation of glycolysis/pyruvate oxidation and alternative metabolic pathways.

resultsTime-weighted mean glucose concentrations were lower with HNC (127 ± 19 mg/dl) than standard care (177 ± 41 mg/dl; P < 0.001). Echocardiographic data were adequate in 72 patients for strain analysis and 67 patients for strain rate analysis. HNC did not improve myocardial strain, with an HNC minus standard therapy difference of -1.2% (97.5% CI, -2.9 to 0.5%; P = 0.11). Strain rate was significantly better, but by a clinically unimportant amount: -0.16 s (-0.30 to -0.03 s; P = 0.007). There was no evidence of increased glycolytic, pyruvate oxidation, or hexosamine biosynthetic pathway activation in right atrial samples (HNC, n = 20; standard therapy, 22).

conclusionAdministration of glucose and insulin while targeting normoglycemia during aortic valve replacement did not meaningfully improve myocardial function.

Indexed as

AdultAgedAged, 80 and overAortic Valve StenosisCardiac Surgical ProceduresFemaleHeart Valve Prosthesis ImplantationHumansHyperinsulinismInsulinIntraoperative CareMaleMiddle AgedProspective StudiesInsulin

Identifiers

PMID26200180
PMCPMC4511921
OpenAlexW2116410560

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.